Compile Data Set for Download or QSAR
maximum 50k data
Found 20 Enz. Inhib. hit(s) with all data for entry = 1098
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141501(US8921370, 2 | US9656975, 2)
Affinity DataKi:  27nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141506(US8921370, 160 | US9656975, 160)
Affinity DataKi:  35nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141505(US8921370, 126 | US9656975, 126)
Affinity DataKi:  39nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141508(US8921370, 171 | US9656975, 171)
Affinity DataKi:  65nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141502(US8921370, 6 | US9656975, 6)
Affinity DataKi:  78nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141504(US8921370, 36 | US9656975, 36)
Affinity DataKi:  280nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141503(US8921370, 15 | US9656975, 15)
Affinity DataKi:  340nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141510(US8921370, 178 | US9656975, 178)
Affinity DataKi:  370nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141509(US8921370, 176 | US9656975, 176)
Affinity DataKi:  500nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141507(US8921370, 161 | US9656975, 161)
Affinity DataKi:  1.20E+3nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141505(US8921370, 126 | US9656975, 126)
Affinity DataIC50:  0.320nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141501(US8921370, 2 | US9656975, 2)
Affinity DataIC50:  3.70nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141506(US8921370, 160 | US9656975, 160)
Affinity DataIC50:  3.90nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141508(US8921370, 171 | US9656975, 171)
Affinity DataIC50:  4.70nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141502(US8921370, 6 | US9656975, 6)
Affinity DataIC50:  9nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141503(US8921370, 15 | US9656975, 15)
Affinity DataIC50:  26nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141509(US8921370, 176 | US9656975, 176)
Affinity DataIC50:  33nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141504(US8921370, 36 | US9656975, 36)
Affinity DataIC50:  35nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141510(US8921370, 178 | US9656975, 178)
Affinity DataIC50:  38nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141507(US8921370, 161 | US9656975, 161)
Affinity DataIC50:  134nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent